Showing 35,310 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined aidsmap in 2008 and was Managing Editor from 2018 to 2024. As a freelancer, he now edits aidsmap’s news and conference coverage, as well as working on updates to About HIV pages. He is also a contributing science editor for TheBodyPro, a freelance journalist for The Lancet HIV, and a medical writer helping researchers prepare articles for peer-reviewed journals. He began working on HIV at Gay Men Fighting AIDS in the mid-1990s.

Finance & funding

Five National HIV Groups Weigh In on Trump’s 2020 Budget Proposal

Editor's pick
POZ
12 March 2019
Treatment simplification strategies

Laura Waters, MD, FRCP: Can Two Drugs Tango?

Editor's pick
Contagion Live
12 March 2019
TB transmission & prevention

Tshepiso study: Preventive TB therapy not associated with poor pregnancy outcomes

Editor's pick
Healio
12 March 2019
PrEP policies & guidelines

Sadiq Khan: Cash row is denying Londoners access to HIV ‘wonder drug’

Editor's pick
Evening Standard
12 March 2019
Finance & funding

Trump’s Budget Offers $291M To Fight HIV In U.S. But Trims Overseas Efforts

Editor's pick
Kaiser Health News
12 March 2019
Drug interactions & pharmacokinetics

Double doses of darunavir given with rifampicin lead to high rates of hepatoxicity

Editor's pick
HIV i-Base
12 March 2019
Global health targets

Largest ever HIV prevention study delivers sobering message

Editor's pick
Science
12 March 2019
Cancer

People with HIV may benefit from earlier lung cancer screening

News
12 March 2019
Self-testing & home testing

Self-testing helps the partners of people with HIV to test, but not to link to care

News
12 March 2019
Retention & linkage to care

India’s first LGBTQ clinic and HIV treatment centre inaugurated in Mumbai

Editor's pick
Hindustan Times
12 March 2019
PrEP policies & guidelines

How Many More Must Needlessly Contract HIV Before We Ensure Proper Access To PrEP?

Editor's pick
Huffington Post
12 March 2019
TB transmission & prevention

Co-administration of dolutegravir-based treatment and short course of rifapentine/isoniazid (3HP) well tolerated in people living with HIV

News
12 March 2019
Hepatitis B

Sixfold increased risk of infant HIV infection and high rates of low birth weight among women with HIV/hepatitis B co-infection

News
12 March 2019
Improving HIV care

EACS takes steps towards a common, auditable European standard of care

News
11 March 2019
Hepatitis C treatment

Pilot study finds HCV treatment safe in pregnancy

Editor's pick
Healio
11 March 2019
PrEP science

Effective HIV Interventions Have Changed the Approach to Trials

Editor's pick
Infectious Diseases Consultant
11 March 2019
Sexually transmitted infections epidemiology

Women Have High Syphilis Rates, Too

Editor's pick
Medscape (requires free registration)
11 March 2019
The search for a cure

What You Need to Know About the Second Person Likely Cured of HIV

Editor's pick
The Body Pro
11 March 2019
How HIV works

HIV-Related Immune Activation May Predict Weight Gain and Exacerbate Complications, Especially in Women

Editor's pick
HIV.gov
11 March 2019
The search for a cure

When Undetectable Is Unachievable: Study Offers Insights into HIV Persistence

Editor's pick
National Institute of Allergy and Infectious Diseases
11 March 2019
Conference announcements & declarations

Really Rapid Review — CROI 2019 Seattle

Editor's pick
NEJM Journal Watch
11 March 2019
The search for a cure

This is Not A Cure for My H.I.V.

Editor's pick
New York Times
11 March 2019
The search for a cure

An H.I.V. Cure: Answers to 4 Key Questions

Editor's pick
New York Times
11 March 2019
New & experimental HIV treatments

HIV capsid inhibitor may offer long-term viral suppression

News
11 March 2019